Literature DB >> 11591099

Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.

A Wiik1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11591099     DOI: 10.1007/s002810100076

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  82 in total

1.  Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.

Authors:  K W Westman; D Selga; P Bygren; M Segelmark; B Baslund; A Wiik; J Wieslander
Journal:  Kidney Int       Date:  1998-05       Impact factor: 10.612

2.  Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis.

Authors:  A Wiik; E Jensen; J Friis
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

Review 3.  Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis.

Authors:  A Wiik
Journal:  Allergy       Date:  1980-06       Impact factor: 13.146

4.  Role of testing for anticytoplasmic autoantibodies in the differential diagnosis of scleritis and orbital pseudotumor.

Authors:  P H Kalina; J A Garrity; D C Herman; R A DeRemee; U Specks
Journal:  Mayo Clin Proc       Date:  1990-08       Impact factor: 7.616

5.  ANCA and predicting relapse in systemic vasculitis.

Authors:  D R Jayne; G Gaskin; C D Pusey; C M Lockwood
Journal:  QJM       Date:  1995-02

6.  A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.

Authors:  J Sun; D N Fass; M A Viss; A M Hummel; H Tang; H A Homburger; U Specks
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

7.  Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.

Authors:  J W Tervaert; L Mulder; C Stegeman; J Elema; M Huitema; H The; C Kallenberg
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

Review 8.  Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.

Authors:  C G Kallenberg; A H Mulder; J W Tervaert
Journal:  Am J Med       Date:  1992-12       Impact factor: 4.965

9.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

Authors:  R Goldschmeding; C E van der Schoot; D ten Bokkel Huinink; C E Hack; M E van den Ende; C G Kallenberg; A E von dem Borne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

10.  Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.

Authors:  A Schnabel; E Csernok; D A Isenberg; C Mrowka; W L Gross
Journal:  Arthritis Rheum       Date:  1995-05
View more
  2 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them?

Authors:  C Beauvillain; Y Delneste; G Renier; P Jeannin; J F Subra; A Chevailler
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 2.  Vasculitis-like Syndromes.

Authors:  Helen Bateman; Aasim Rehman; Joanne Valeriano-Marcet
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.